Market research
TLIS Talis Biomedical Corp
PINK USD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 5
- Dividend yield
- Not available
- Beta
- 1.32
Community
Investor discussion
1 comment
Sign in to join the TLIS discussion.
5 years, 4 months ago
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 23.2.
Based on the above factors, Talis Biomedical Corporation Common Stock gets an overall score of 1/5.